Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06608290
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-19
Brief Title:
Paraesternal Blockade and Lactate Serum Levels in Patients with Cardiac Surgery
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Association Between the Application of Parasternal Blockade and Serum Lactate Level in Trans and Post-anesthetic Stages in Cardiac Surgery
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Parasternal blockade has been related to a reduction of the postoperative inflammatory response by inhibition of the stress response leading to a better prognosis Increased lactate level is a useful parameter in identifying patients at risk of postoperative morbidity and mortality The objective was to evaluate the association between parasternal blockade and serum lactate level in patients undergoing cardiac surgery both trans- and post-anesthesia 86 patients between 60-70 years of age participated An association was found between the application of parasternal blockade in cardiac surgery and the presence of lower trans and postanesthetic serum lactate levels
Detailed Description:
An analytical cross-sectional study in adult patients who underwent elective cardiac surgery A total sample of 86 patients was obtained 43 in the case group and 43 in the control group Adult patients older than 18 years of either sex with ASA II-III patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass were included
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None